ALEMBIC PHARMACEUTICALS LTD SHARE PRICE [LIVE]

  
NSE: APLLTD
496.35
BSE: 533573
491.25
To view real time prices Login to your account
OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality

Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
-33.07%
Sector
-10.76%
Sensex
0.72%
Underperformed both Sector by -22.31% and Sensex by -33.79%
IndustryPharma
MARKET CAP (Mid Cap Stock)Rs 9,789 Cr
PE (TTM) 40.94
DIVIDEND YIELD 2.14%
PE Ratio42.94
Price to Book Value1.89
EV to EBIT31.20
EV to EBITDA15.78
EV to Capital Employed1.78
EV to Sales1.83
PEG Ratio0.00
Dividend Yield2.04%
ROCE (Latest)5.76%
ROE (Latest)5.37%
NameDec 22Sep 22
Promoters (Change:-0.00) 69.61%69.61%
FIIs (Change:-0.33) 4.99%5.32%
Mutual Funds (Change:0.51) 5.87%5.36%
Insurance Companies (Change:-0.43) 6.6%7.03%
Other DIIs (Change:0.13) 0.28%0.15%
Non Institution (Change:0.12) 12.65%12.53%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in ALEMBIC PHARMACEUTICALS LTD

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

APLLTD News

Frequently Asked Questions

What is the Share price of ALEMBIC PHARMACEUTICALS LTD. (APLLTD)?

ALEMBIC PHARMACEUTICALS LTD. (APLLTD) share price as of April 1, 2023, on NSE is Rs 496.35 (NSE) and Rs 491.25 (BSE) on BSE.

Can I buy ALEMBIC PHARMACEUTICALS LTD. (APLLTD) shares?

Yes, You can buy ALEMBIC PHARMACEUTICALS LTD. (APLLTD) shares by opening a Demat account with Angel One.

How do I buy ALEMBIC PHARMACEUTICALS LTD. (APLLTD) from Angel One?

ALEMBIC PHARMACEUTICALS LTD. (APLLTD) share can be brought through the following modes:
  1. Direct investment: You can buy ALEMBIC PHARMACEUTICALS LTD. (APLLTD) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to ALEMBIC PHARMACEUTICALS LTD. (APLLTD) shares.

In which sector do ALEMBIC PHARMACEUTICALS LTD. (APLLTD) belong?

ALEMBIC PHARMACEUTICALS LTD. (APLLTD) belongs to Pharma.

Is Alembic Pharmaceuticals a Debt free Company?

No, Alembic Pharmaceuticals is not a debt free company.

What is the main business of Alembic Pharmaceuticals?

The main business of Alembic Pharmaceuticals is to develop and manufacture generic pharmaceutical substances, intermediates, and pharmaceutical products.

Who are the promoters of Alembic Pharmaceuticals?

The main promoters of Alembic Pharmaceuticals include Nirayu Limited, Alembic Limited, Chirayu Ramanbhai Amin, Malika Chirayu Amin, Pranav Chirayu Amin, Shaunak Chirayu Amin, Udit Chirayu Amin, Inaaya Shaunak Amin, Naintara Shaunak Amin, Ranvir Pranav Amin, and Samira Pranav Amin.

What are the Subsidiaries that comes under Alembic Pharmaceuticals?

The main subsidiaries that come under Alembic Pharmaceuticals are Alembic Pharmaceuticals Inc., Alembic Global Holding SA, Alembic Pharmaceuticals Australia Pty Ltd, Alembic Pharmaceuticals Europe Ltd., Alnova Pharmaceuticals SA, Alembic Labs LLC, Alembic Pharmaceuticals Canada Ltd., and Genius LLC.

About APLLTD

Today's live share price for ALEMBIC PHARMACEUTICALS LTD is NSE: ₹ 496.35, BSE: ₹ 491.25 with a current market capitalization of .

Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in Pharamceulicals business. As per the scheme of arrangement, the "Pharmaceutical Undertaking" of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement, the shareholding of Alembic Ltd in the company reduced from 100% to 29.18%. Thus, the company became an associate of Alembic Ltd. In September 20, 2011, the equity shares of the company were listed on the Bombay Stock Exchange and National Stock Exchange. During 2012, Alembic and Breckenridge Announced Paragraph IV ANDA Litigation with Pfizer on Desvenlafaxine (Pristiq). The company enters into a product development and license agreement with Accu-Break Pharmaceuticals, Inc, USA. During 2013, the company got USFDA approval for its NDA - Desvenlafaxine Base Extended Release Tablets and also entered into an out-licensing agreement with Ranbaxy Pharmaceuticals Inc (Ranbaxy) to market its product in USA. During 2014, the company announces joint venture with Adwiya Mami SARL Algeria through its wholly owned Subsidiary - Alembic Global Holding S.A.". During 2015, the companies associate signs exclusive agreement with Novartis.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers